Lumida
/PRLB
⌘K
Proto Labs Inc

Proto Labs Inc

PRLB
$77.62USD↑+0.34%+0.26 today

MARKET CAP

1.8B

P/E (TTM)

41.7x

FWD P/E

37.7x

DAY RANGE

$74 – $79

52W RANGE

$38
$83

AI Summary

Stalk
Sell NowMedium

PRLB is in a Stage 4 structural decline with medium confidence. The medium-term bias is bearish, reinforced by an active Bearish Pivot Point signaling structural repair downward. Short-term conditions show price below the 9 and 21 EMAs and rejecting resistance, making now an opportune moment for sell-side execution. While the long-term trend remains up, intermediate weakness dominates, justifying immediate sell participation around resistance areas.

  • ↑Q1 revenue $139.3M (+10.4% YoY) driven by 17.6% CNC machining growth.
  • ↑Non-GAAP EPS rose 64% YoY to $0.54, signaling strong margin expansion.
  • ↓Negative profitability factors reflect margin compression from rising costs.
Full analysis →

The case for & against

Bull & Bear analysis

Bullish

Proto Labs, Inc. (NASDAQ: PRLB) is a leading digital manufacturing company that specializes in rapid prototyping and custom manufacturing services, focusing on industries such as aerospace, defense, medical devices, and robotics. The company utilizes advanced technologies, including CNC machining and 3D printing, to meet the rising demand for quick turnaround times and high-quality custom parts. As a pioneer in the on-demand manufacturing space, Proto Labs is strategically positioned to capitalize on innovation-driven trends, enhancing its market presence and operational capabilities.

Bull says

  • ↑Q1 revenue $139.3M (+10.4% YoY) driven by 17.6% CNC machining growth.
  • ↑Non-GAAP EPS rose 64% YoY to $0.54, signaling strong margin expansion.
  • ↑Drone segment revenue surged 90% since 2023, broadening market reach.
  • ↑Revenue per customer up 20% YoY; combined offerings usage climbed 44%.
  • ↑Operating cash flow of $17.5M in Q1 underscores healthy FCF generation.
  • ↑Analyst upgrades, positive momentum, strong liquidity, and low leverage support valuation.

Bear says

  • ↓Negative profitability factors reflect margin compression from rising costs.
  • ↓Europe sales declined 3.4% YoY amid manufacturing slowdown and geopolitical risks.
  • ↓High reliance on a few strategic clients raises customer concentration risk.
  • ↓Stock trades with high volatility and significant short interest.
  • ↓Low institutional ownership suggests limited market conviction.
  • ↓2026 revenue guidance of just 6–8% growth reflects cautious outlook.

Earnings Call · Q1 2025 · Mgmt. Guidance

Updated 06-15-2026neutral

Transcript signals

Bull points

  • welcome to ProtoLab's first quarter 2025 earnings conference call.
  • Revenue fulfilled through Protolab's network was $26.3 million, up 11.5% in constant currencies.
  • We generated $18.4 million in cash from operations during the first quarter, and we returned $20.9 million to shareholders in the form of repurchases, or 122 percent of free cash flow.

Bear points

  • First quarter revenue came in at $126.2 million toward the upper end of our guidance range and down 1% year-over-year in constant currencies.
  • U.S. revenue was down 1.2% compared to the prior year.
  • Injection molding revenue declined 7% versus the prior year, mainly due to non-recurring larger part orders in the first quarter of 2024.
Read full transcript analysis ›